WealthStone’s Labcorp LH Stock Holding History

WealthStone’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-26	Closed	-$3.8K	–	350
2019 Q2	$3.8K	Buy	+26	New	+$3.63K	﹤0.01%	396

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WealthStone's LH Position: Q3 2019 in Review

WealthStone sold out of Labcorp (LH) in Q3 2019, closing a stake of 26 shares — an estimated $3.8K sold.

WealthStone first reported a position in LH in Q2 2019 and held it in 1 quarter. The position peaked at $3.8K in Q2 2019. 738 funds tracked by Wall St. Rank hold LH as of Q3 2019.

WealthStone reported no remaining Labcorp position as of Q3 2019 after selling out during the quarter.
WealthStone sold 26 Labcorp shares in Q3 2019, an estimated $3.8K.
WealthStone first reported a position in Labcorp in Q2 2019 and held it in 1 quarter.
WealthStone's Labcorp position peaked at $3.8K in Q2 2019.
738 funds tracked by Wall St. Rank held Labcorp as of Q3 2019.

Based on WealthStone's 13F filing for Q3 2019, filed 15 Nov 2019.